The genetics of attention deficit hyperactivity disorder

Human Molecular Genetics

Volumn 14, Issue SUPPL. 2, 2005, Pages

  Thapar, Anita ^a   O'Donovan, Michael ^a   Owen, Michael J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE TRANSPORTER; GUANINE NUCLEOTIDE BINDING PROTEIN; METHYLPHENIDATE; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG;

ARTICLE; ATTENTION DEFICIT DISORDER; CHROMOSOME ANALYSIS; CLINICAL TRIAL; COGNITIVE DEFECT; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG PROTEIN BINDING; ENVIRONMENTAL FACTOR; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IN VITRO STUDY; LOW BIRTH WEIGHT; META ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENVIRONMENT; HUMANS; META-ANALYSIS; MODELS, BIOLOGICAL; RECEPTORS, DOPAMINE D4; RECEPTORS, DOPAMINE D5; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

ANIMALIA;

EID: 27744455936     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi263     Document Type: Article

References (98)

1. Thapar, A., Holmes, J., Poulton, K. and Harrington, R. (1999) Genetic basis of attention deficit and hyperactivity. Br. J. Psychiatry, 174, 105-111.
2. Bobb, A.J., Castellanos, F.X., Addington, A.M. and Rapoport, J.L. (2005) Molecular genetic studies of ADHD: 1991 to 2004. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 132(1), 109-125.
3. Asherson, P., IMAGE Consortium. (2004) Attention-deficit hyperactivity disorder in the post-genomic era. Eur. Child. Adol. Psych., 13(Suppl.1), 150-170.
4. Castellanos, F.X. (2001) Neuroimaging Studies of ADHD. In Solanto, M.V., Tarnsten, A.F.T. and Castellanos, F.X. (eds), Stimulant Drugs and ADHD. Oxford University Press, Oxford, UK, pp. 243-258.
5. Volkow, N.D. and Swanson, J.M. (2003) Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am. J. Psych., 160, 1909-1918.
6. Arnsten, A.F. and Dudley, A.G. (2005) Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav. Brain Funct., 1(1), 2.
7. Castellanos, F.X., Lee, P.P., Sharp, W., Jeffries, N.O., Greenstein, D.K., Clasen, L.S., Blumenthal, J.D., James, R.S., Ebens, C.L., Walter, J.M., Zijdenbos, A., Evans, A.C., Giedd, J.N., Rapoport, J.L. (2002) Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA., 9;288(14):1740-1748.
8. Castellanos, F.X., Sharp, W.S., Gottesman, R.F., Greenstein, D.K., Giedd, J.N. and Rapoport, J.L. (2003) Anatomic brain abnormalities in monozygotic twins discordant for attention deficit hyperactivity disorder. Am. J. Psych., 160, 1693-1696.
9. Dougherty, D.D., Bonab, A.A., Spencer, T.J., Rauch, S.L., Madras, B.K. and Fischman, A.J. (1999) Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet, 354, 2132-2133.
10. Jucaite, A., Fernell, E., Halldin, C., Forssberg, H. and Farde, L. (2005) Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity. Biol. Psychiatry, 57, 229-238.
11. Dresel, S., Krause, J., Krause, K.H., LaFougere, C., Brinkbaumer, K., Kung, H.F., Hahn, K. and Tatsch, K. (2000) Attention deficit hyperactivity disorder: Binding of [99mTc] TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur. J. Nucl. Med., 27(10), 1518-1524.
12. van Dyck, C.H., Quinlan, D.M., Cretella, L.M., Staley, J.K., Malison, R.T., Baldwin, R.M., Seibyl, J.P. and Innis, R.B. (2002) Unaltered dopamine transporter availability in adult attention deficit hyperactivity disorder. Am. J. Psychiatry, 159(2), 309-312.
13. Giros, B., Jaber, M., Jones, S.R., Wightman, R.M. and Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606-612.
14. Tan, S., Hermann, B. and Borrelli, E. (2003) Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter. Int. Rev. Neurobiol., 54, 145-197.
15. Viggiano, D., Ruocco, L.A. and Sadile, A.G. (2003) Dopamine phenotype and behaviour in animal models: In relation to attention deficit hyperactivity disorder. Neurosci. Biobehav. Rev., 27, 623-637.
16. Dulawa, S.C., Grandy, D.K., Low, M.J., Oaulus, M.P. and Geyer, M.A. (1999) Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci., 19(21), 9550-9556.
17. Gainetdinov, R.R., Wetsel, W.C., Jones, S.R., Levin, E.D., Jaber, M. and Caron, M.G. (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science, 283, 397-401.
18. Gainetdinov, R.R. and Caron, M.G. (2000) An animal model of attention deficit hyperactivity disorder. Mol. Med. Today, 6, 43-44.
19. Faraone, S.V., Perlis, R.H., Doyle, A.E., Smoller, J.W., Goralnick, J.J., Holmgren, M.A. and Sklar, P. (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry, 57(11), 1313-1323.
20. Van Tol, H.H., Bunzow, J.R., Guan, H.C., Sunahara, R.K., Seeman, P., Niznik, H.B. and Civelli, O. (1991) Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature, 350(6319), 610-614.
21. Oak, J.N., Oldenhof, J. and Van Tol, H.H. (2000) The dopamine D(4) receptor: One decade of research. Eur. J. Pharmacol., 405(1-3), 303-327.
22. Ding, Y.C., Chi, H.C., Grady, D.L., Morishima, A., Kidd, J.R., Kidd, K.K., Flodman, P., Spence, M.A., Schuck, S., Swanson, J.M. et al. (2002) Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proc. Natl Acad. Sci. USA, 99(1), 309-314.
23. Wang, E., Ding, Y.C., Flodman, P., Kidd, J.R., Kidd, K.K., Grady, D.L., Ryder, O.A., Spence, M.A., Swanson, J.M. and Moyzis, R.K. (2004) The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am. J. Hum. Genet., 74(5), 931-944.
24. Ebstein, R.P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., Bennett, E.R., Nemanov, L., Katz, M. and Belmaker, R.H. (1996) Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat. Genet., 12(1), 78-80.
25. LaHoste, G.J., Swanson, J.M., Wigal, S.B., Glabe, C., Wigal, T., King, N. and Kennedy, J.L. (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry, 1(2), 121-124.
26. Schinka, J.A., Letsch, E.A. and Crawford, F.C. (2002) DRD4 and novelty seeking: Results of meta-analyses. Am. J. Med. Genet., 114(6), 643-648.
27. Faraone, S.V., Doyle, A.E., Mick, E. and Biederman, J. (2001) Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am. J. Psych., 158, 1052-1057.
28. Asghari, V., Sanyal, S., Buchwaldt, S., Paterson, A., Jovanovic, V. and Van Tol, H.H. (1995) Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem., 65(3), 1157-1165.
29. Lichter, J.B., Barr, C.L., Kennedy, J.L., Van Tol, H.H., Kidd, K.K. and Livak, K.J. (1993) A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum. Mol. Genet., 2(6), 767-773.
30. Grady, D.L., Chi, H.C., Ding, Y.C., Smith, M., Wang, E., Schuck, S., Flodman, P., Spence, M.A., Swanson, J.M. and Moyzis, R.K. (2003) High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol. Psychiatry, 8(5), 536-545.
31. Daly, G., Hawi, Z., Fitzgerald, M. and Gill, M. (1999) Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry, 4(2), 192-196.
32. Maher, B.S., Marazita, M.L., Ferrell, R.E. and Vanyukov, M.M. (2002) Dopamine system genes and attention deficit hyperactivity disorder: A meta-analysis. Psychiatr. Genet., 12(4), 207-215.
33. Lowe, N., Kirley, A., Hawi, Z., Sham, P., Wickham, H., Kratochvil, C.J., Smith, S.D., Lee, S.Y., Levy, F., Kent, L., et al. (2004) Joint analysis of the DRD5 marker concludes association with attention-deficit/ hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am. J. Hum. Genet., 74(2), 348-356.
34. Hawi, Z., Lowe, N., Kirley, A., Gruenhage, F., Nothen, M., Greenwood, T., Kelsoe, J., Fitzgerald, M. and Gill, M. (2003) Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol. Psychiatry, 8(3), 299-308.
35. Weinshank, R.L., Adham, N., Macchi, M., Olsen, M.A., Branchek, T.A. and Hartig, P.R. (1991) Molecular cloning and characterization of a high affinity dopamine receptor (D1 beta) and its pseudogene. J. Biol. Chem., 266(33), 22427-22435.
36. Cook, E.H., Jr, Stein, M.A., Krasowski, M.D., Cox, N.J., Olkon, D.M., Kieffer, J.E. and Leventhal, B.L. (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet., 56(4), 993-998.
37. Curran, S., Mill, J., Sham, P., Rijsdijk, F., Marusic, K., Taylor, E. and Asherson, P. (2001) QTL association analysis of the DRD4 exon 3 VNTR polymorphism in a population sample of children screened with a parent rating scale for ADHD symptoms. Am. J. Med. Genet., 105(4), 387-393.
38. Faraone, S.V., Perlis, R.H., Doyle, A.E., Smoller, J.W., Goralnick, J.J., Holmgren, M.A. and Sklar, P. (2005) Molecular genetics of attention deficit hyperactivity disorder. Biol. Psychiatry, 57(11), 1313-1323.
39. Heinz, A., Goldman, D., Jones, D.W., Palmour, R., Hommer, D., Gorey, J.G., Lee, K.S., Linnoila, M. and Weinberger, D.R. (2000) Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology, 22(2), 133-139.
40. Greenwood, T.A. and Kelsoe, J.R. (2003) Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics, 82(5), 511-520.
41. Mill, J., Xu, X., Ronald, A., Curran, S., Price, T., Knight, J., Craig, I., Sham, P., Plomin, R. and Asherson, P. (2005) Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25 and 5HT1B. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 133(1), 68-73.
42. Barr, C.L., Xu, C., Kroft, J., Feng, Y., Wigg, K., Zai, G., Tannock, R., Schachar, R., Malone, M., Roberts, W. et al. (2001) Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder. Biol. Psychiatry, 49(4), 333-339.
43. Langley, K., Turic, D., Peirce, T.R., Mills, S., van den Bree, M.B., Owen, M.J., O'Donovan, M.C. and Thapar, A. (2005) No support for association between the dopamine transporter (DAT1) gene and ADHD. Am. J. Med. Genet. B. Neuropsychiatr. Genet., (Epub ahead of print, August 4, 2005).
44. Sollner, T., Whiteheart, S.W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P. and Rothman, J.E. (1993) SNAP receptors implicated in vesicle targeting and fusion. Nature, 362, 318-324.
45. Hess, E.J., Collins, K.A. and Wilson, M.C. (1996) Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. J. Neurosci., 16(9), 3104-3111.
46. Washbourne, P., Thompson, P.M., Carta, M., Costa, E.T., Mathews, J.R., Lopez-Bendito, G., Molnar, Z., Becher, M.W., Valenzuela, C.F., Partridge, L.D. and Wilson, M.C. (2002) Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. Nat. Neurosci., 5(1), 19-26.
47. Barr, C.L., Feng, Y., Wigg, K., Bloom, S., Roberts, W., Malone, M., Schachar, R., Tannock, R. and Kennedy, J.L. (2000) Identification of DNA variants in the SNAP-25 gene and linkage study of these polymorphisms and attention-deficit hyperactivity disorder. Mol. Psychiatry, 5(4), 405-409.
48. Mill, J., Asherson, P., Browes, C., D'Souza, U. and Craig, I. (2002) Expression of the dopamine transporter gene is regulated by the 3′-UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am. J. Med. Genet., 114(8), 975-979.
49. Brophy, K., Hawi, Z., Kirley, A., Fitzgerald, M. and Gill, M. (2002) Synaptosomal-associated protein 25 (SNAP-25) and attention deficit hyperactivity disorder (ADHD): Evidence of linkage and association in the Irish population. Mol. Psychiatry, 7(8), 913-917.
50. Kustanovich, V., Merriman, B., McGough, J., McCracken, J.T., Smalley, S.L. and Nelson, S.F. (2003) Biased paternal transmission of SNAP-25 risk alleles in attention-deficit hyperactivity disorder. Mol. Psychiatry, 8(3), 309-315.
51. Mill, J., Richards, S., Knight, J., Curran, S., Taylor, E. and Asherson, P. (2004) Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol. Psychiatry, 9(8), 801-810.
52. Montecucco, C., Schiavo, G. and Pantano, S. (2005) SNARE complexes and neuroexocytosis: How many, how close? Trends Biochem. Sci., 10.1016/ j.tibs.2005.05.002.
53. Jones, M.D. and Hess, E.J. (2003) Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma. Pharmacol. Biochem. Behav., 75(1), 209-216.
54. Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muller, C.R., Hamer, D.H. and Murphy, D.L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274(5292), 1527-1531.
55. Greenberg, B.D., Tolliver, T.J., Huang, S.J., Li, Q., Bengel, D. and Murphy, D.L. (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am. J. Med. Genet., 88(1), 83-87.
56. Kent, L., Doerry, U., Hardy, E., Parmar, R., Gingell, K., Hawi, Z., Kirley, A., Lowe, N., Fitzgerald, M., Gill, M. and Craddock, N. (2002) Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol. Psychiatry, 7(8), 908-912.
57. Seeger, G., Schloss, P. and Schmidt, M.H. (2001) Marker gene polymorphisms in hyperkinetic disorder - predictors of clinical response to treatment with methylphenidate? Neurosci. Lett., 313(1-2), 45-48.
58. Manor, I., Eisenberg, J., Tyano, S., Sever, Y., Cohen, H., Ebstein, R.P. and Kotler, M. (2001) Family-based association study of the serotonin transporter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am. J. Med. Genet., 105(1), 91-95.
59. Kent, L., Doerry, U., Hardy, E., Parmar, R., Gingell, K., Hawi, Z., Kirley, A., Lowe, N., Fitzgerald, M., Gill, M. and Craddock, N. (2002) Evidence that variation at the serotonin transporter gene influences susceptibility to attention deficit hyperactivity disorder (ADHD): analysis and pooled analysis. Mol. Psychiatry, 7(8), 908-912.
60. Langley, K., Payton, A., Hamshere, M.L., Pay, H.M., Lawson, D.C., Turic, D., Ollier, W., Worthington, J., Owen, M.J., O'Donovan, M.C. and Thapar, A. (2003) No evidence of association of two 5HT transporter gene polymorphisms and attention deficit hyperactivity disorder. Psychiatr. Genet., 13(2), 107-110.
61. Zoroglu, S.S., Erdal, M.E., Alasehirli, B., Erdal, N., Sivasli, E., Tutkun, H., Savas, H.A. and Herken, H. (2002) Significance of serotonin transporter gene 5-HTTLPR and variable number of tandem repeat polymorphism in attention deficit hyperactivity disorder. Neuropsychobiology, 45(4), 176-181.
62. Retz, W., Thome, J., Blocher, D., Baader, M. and Rosler, M. (2002) Association of attention deficit hyperactivity disorder-related psychopathology and personality traits with the serotonin transporter promoter region polymorphism. Neurosci. Lett., 319(3), 133-136.
63. Curran, S., Purcell, S., Craig, I., Asherson, P. and Sham, P. (2005) The serotonin transporter gene as a QTL for ADHD. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 134(1), 42-47.
64. Brunner, D., Buhot, M.C., Hen, R. and Hofer, M. (1999) Anxiety, motor activation, and maternal-infant interactions in 5HT1B knockout mice. Behav. Neurosci., 113(3), 587-601.
65. Quist, J.F., Barr, C.L., Schachar, R., Roberts, W., Malone, M., Tannock, R., Basile, V.S., Beitchman, J. and Kennedy, J.L. (2003) The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol. Psychiatry, 8(1), 98-102.
66. Hawi, Z., Dring, M., Kirley, A., Foley, D., Kent, L., Craddock, N., Asherson, P., Curran, S., Gould, A., Richards, S. et al. (2002) Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol. Psychiatry, 7(7), 718-725.
67. Ogdie, M.N., Macphie, I.L., Minassian, S.L., Yang, M., Fisher, S.E., Francks, C., Cantor, R.M., McCracken, J.T., McGough, J.J., Nelson, S.F. et al. (2003) A genome wide scan for attention-deficit/hyperactivity disorder in an extended sample: Suggestive linkage on 17p11. Am. J. Hum. Genet., 72(5), 1268-1279.
68. Bakker, S.C., van der Meulen, E.M., Buitelaar, J.K., Sandkuijl, L.A., Pauls, D.L., Monsuur, A.J., van't Slot, R., Minderaa, R.B., Gunning, W.B., Pearson, P.L. and Sinke, R.J. (2003) A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am. J. Hum. Genet., 72(5), 1251-1260.
69. Arcos-Burgos, M., Castellanos, F.X., Pineda, D., Lopera, F., Palacio, J.D., Palacio, L.G., Rapoport, J.L., Berg, K., Bailey-Wilson, J.E. and Muenke, M. (2004) Attention-deficit/hyperactivity disorder in a population isolate: Linkage to loci at 4q13.2, 5q33.3, 11q22 and 17p11. Am. J. Hum. Genet., 75(6), 998-1014.
70. Ogdie, M.N., Fisher, S.E., Yang, M., Ishii, J., Francks, C., Loo, S.K., Cantor, R.M., McCracken, J.T., McGough, J.J., Smalley, S.L. and Nelson, S.F. (2004) Attention deficit hyperactivity disorder: Fine mapping supports linkage to 5p13, 6q12, 16p13 and 17p11. Am. J. Hum. Genet., 75(4), 661-668.
71. Katcher, S., Aman, M., Brooks, S.J., Buitelaar, J., van Daalen, E., Fegert, J., Findling, R.L., Fisman, S., Greenhill, L.L. Huss, M. et al. (2004) International consensus statement on attention-deficit/ hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur. Neuropsychopharmacol., 14(1), 11-28.
72. Taylor, E., Chadwick, O., Heptinstall, E. and Danckaerts, M. (1996) Hyperactivity and conduct problems as risk factors for adolescent development. J. Am. Acad. Child. Adolesc. Psychiatry, 35(9), 1213-1226.
73. Rutter, M., Giller, H. and Hagell, A. (1998) Antisocial Behavior by Young People. Cambridge University Press, UK.
74. Moffitt, T.E. (1993) Adolescence-limited and life-course-persistent antisocial behavior: A developmental taxonomy. Psychol. Rev., 100(4), 674-701.
75. Thapar, A., Harrington, R., McGuffin, P. (2001) Examining the comorbidity of ADHD related behaviours and conduct problems using a twin study design. British Journal of Psychiatry, 179, 224-229.
76. Holmes, J., Payton, A., Barrett, J., Harrington, R., McGuffin, P., Owen, M., Ollier, W., Worthington, J., Gill, M., Kirley, A. et al. (2002) Association of DRD4 in children with ADHD and comorbid conduct problems. Am. J. Med. Genet., 114(2), 150-153.
77. Kirley, A., Lowe, N., Mullins, C., McCarron, M., Daly, G., Waldman, I., Fitzgerald, M., Gill, M. and Hawi, Z. (2004) Phenotype studies of the DRD4 gene polymorphisms in ADHD: Association with oppositional defiant disorder and positive family history. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 131(1), 38-42.
78. Lowe, N., Kirley, A., Hawi, Z., Sham, P., Wickham, H., Kratochvil, C.J., Smith, S.D., Lee, S.Y., Levy, F., Kent, L. et al. (2004) Joint analysis of the DRD5 marker concludes association with attention-deficit/ hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am. J. Hum. Genet., 74(2), 348-356.
79. El-Faddagh, M., Laucht, M., Maras, A., Vohringer, L. and Schmidt, M.H. (2003) Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: A longitudinal study from birth to 11 years of age. J. Neural. Transm., 111(7), 883-889.
80. Castellanos, F.X. and Tannock, R. (2002) Neuroscience of attention-deficit/hyperactivity disorder: The search for endophenotypes. Nat. Rev. Neurosci., 3(8), 617-628.
81. Barkley, R.A. (1998) Attention-Deficit Hyperactivity Disorder, 2nd edn. The Guilford Press, New York.
82. Langley, K., Marshall, L., van den Bree, M., Thomas, H., Owen, M., O'Donovan, M. and Thapar, A. (2004) Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am. J. Psychiatry, 161(1), 133-138.
83. Manor, I., Tyano, S., Eisenberg, J., Bachner-Melman, R., Kotler, M. and Ebstein, R.P. (2002) The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol. Psychiatry, 7(7), 790-794.
84. Swanson, J., Oosterlaan, J., Murias, M., Schuck, S., Flodman, P., Spence, M.A., Wasdell, M., Ding, Y., Chi, H-C., Smith, M. et al. (2000) Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc. Natl Acad. Sci. USA, 97(9), 4754-4759.
85. Bellgrove, M.A., Hawi, Z., Lowe, N., Kirley, A., Robertson, I.H. and Gill, M. (2005) DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): Effects of associated alleles at the VNTR and -521 SNP. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 10.1002/ajmg.b.30193.
86. Durston, S., Fossella, J.A., Casey, B.J., Hilshoff Pol, H.E., Galvan, A., Schnack, H.G., Steenhuis, M.P., Minderaa, R.B., Buitelaar, J.K., Kahn, R.S. and van Engeland, H. (2005) Differential effects of DRD4 and DAT1 genotype on front-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol Psychiatry, 10.1038/sj.mp.4001649.
87. Szobot, C., Roman, T., Cunha, R., Acton, P., Hutz, M. and Rohde, L.A. (2005) Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet., 132(1), 53-58.
88. Waldman, I.D., Rowe, D.C., Abramowitz, A., Kozel, S.T., Mohr, J.H., Sherman, S.L., Cleveland, H.H., Sanders, M.L., Gard, J.M. and Stever, C. (1998) Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am. J. Hum. Genet., 63(6), 1767-1776.
89. Thapar, A., Fowler, T., Rice, F., Scourfield, J., van den Bree, M., Thomas, H., Harold, G. and Hay, D. (2003) Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am. J. Psych., 160(11), 1985-1989.
90. Linnet, K.M., Dalsgaard, S., Obel, C., Wisborg, K., Henriksen, T.B., Rodriguez, A., Kotimaa, A., Moilanen, I., Thomsen, P.H., Olsen, J. and Jarvelin, M.R. (2003) Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am. J. Psychiatry, 160(6), 1028-1040.
91. Bhutta, A.T., Cleves, M.A., Casey, P.H., Cradock, M.M. and Anand, K.J. (2002) Cognitive and behavioral outcomes of school-aged children who were born preterma meta-analysis. JAMA., 288(6), 728-737.
92. Tiret, L. (2002) Gene-environment interaction: A central concept in multifactorial diseases. Proc. Nutr. Soc., 61(4), 457-463.
93. Rutter, M. and Silberg, J. (2002) Gene-environment interplay in relation to emotional and behavioral disturbance. Annu. Rev. Psychol., 53, 463-490.
94. Caspi, A., McClay, J., Moffitt, T.E., Mill, J., Martin, J., Craig, I.W., Taylor, A. and Poulton, R. (2002) Role of genotype in the cycle of violence in maltreated children. Science, 297(5582), 851-854.
95. Hauser, E.R., Hsu, F.C., Daley, D., Olson, J.M., Rampersaud, E., Lin, J.P., Paterson, A.D., Poisson, L.M., Chase, G.A., Dahmen, G. and Ziegler, A. (2003) Effects of covariates: A summary of group 5 contributions. Genet. Epidemiol., 25 (Suppl. 1), S43-S49.
96. Khan, R.S., Khoury, J., Nichols, W.C. and Lanphear, B.P. (2003) Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive and oppositional behaviors. J. Pediatr., 143(1), 104-110.
97. Thapar, A. (2002) Attention Deficit Hyperactivity Disorder: New Genetic Findings, New Directions. In: Behavioural Genetics in the Postgenomic Era. Plomin R, DeFries J, Craig I, McGuffin P. Washington: APA. 445-462.
98. Speca, D.J., Rabbee, N., Chihara, D., Speed, T.P. and Peterson, A.S. (2005) A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in mice. Genes, Brain Behav., 10.1111/ j.1601-183X.2005.00127.x.